Influence of nonalcoholic steatohepatitis on the structural and functional conditions of the heart in patients with arterial hypertension, complicated by congestive heart failure
DOI:
https://doi.org/10.15587/2519-4798.2016.72538Keywords:
nonalcoholic steatohepatitis, arterial hypertension, chronic heart failure, structural and functional conditions of the heartAbstract
At the present time nonalcoholic fatty liver disease is often regarded as one of the components of metabolic syndrome (MS), which may contribute to the development and progression of cardiovascular disease. The aim of the study was to investigate the influence of nonalcoholic steatohepatitis (NASH) on the structural and functional conditions of the heart in patients with arterial hypertension (AH) complicated by chronic heart failure (CHF).
Methods. In 126 examinating patients with diagnosed and adjusted by medication AH complicated by CHF III-IV functional class NYHA indicators of the liver functional state and blood lipids were determined. Structural and functional conditions of the heart were assessed by echocardiography. Statistical analysis of the results was performed using "Statistica 10 Enterprise x64" ("Stat Soft", USA).
Results. The presence of NASH was accompanied by violation of the liver functional state with moderate cytolytic and cholestatic syndromes and dyslipidemia in patients with AH complicated by CHF. A direct correlations between an atherogenic coefficient and activities of alaninaminotrasferase and hammahlutamiltranspeptydase in blood were revealed. It was found an adverse influence of NASH on the indicators of intra-cardiac hemodynamics and remodeling of the left ventricle (LV) to increase the thickness of the LV posterior wall, interventricular septum (IVS), myocardial mass and reduce the LV ejection fraction.
Conclusions. The presence of NASH in patients with AH complicated by CHF adversely affect on structural and functional conditions of the heart and intra-cardiac hemodynamics and contributes to the progression of heart failure.
References
- Voronkov, L. G. (2012). Pacijent iz HSN v Ukrai'ni: analiz usijei' populjacii' pacijentiv, obstezhenyh u ramkah pershogo nacional'nogo zrizovogo doslidzhennja UNIVERS. Serceva nedostatnist', 1, 8–13.
- Netjazhenko, V. Z., Bidzilja, P. P. (2014). Strukturni zminy miokarda pry hronichnij sercevij nedostatnosti II funkcional'nogo klasu na tli nadlyshkovoi' masy tila ta abdominal'nogo ozhyrinnja. Zaporozhskyj medycynskyj zhurnal, 2 (83), 22–25.
- Shevchenko, O. S. (2005). Zastojnaja pechen' pri hronicheskoj serdechnoj nedostatochnosti. Vrachebnaja praktika, 5, 60–64.
- Alvarez, A., Mukherjee, D. (2011). Liver Abnormalities in Cardiac Diseases and Heart Failure. International Journal of Angiology, 20 (03), 135–142. doi: 10.1055/s-0031-1284434
- Harchenko, V. V. (2012). Osoblyvosti porushen' endoteliju ta strukturno-funkcional'nogo stanu erytrocytu u hvoryh na nealkogol'nyj steatogepatyt u pojednanni z gipertonichnoju hvoroboju. Fitoterapija, 4, 23–27.
- Farrell, G. C., Larter, C. Z. (2006). Nonalcoholic fatty liver disease: From steatosis to cirrhosis. Hepatology, 43 (S1), S99–S112. doi: 10.1002/hep.20973
- Bedogni, G., Kahn, H. S., Bellentani, S., Tiribelli, C. (2010). A simple index of lipid overaccumulation is a good marker of liver steatosis. BMC Gastroenterology, 10 (1), 98. doi: 10.1186/1471-230x-10-98
- Lonardo, A., Ballestri, S., Marchesini, G., Angulo, P., Loria, P. (2015). Nonalcoholic fatty liver disease: A precursor of the metabolic syndrome. Digestive and Liver Disease, 47 (3), 181–190. doi: 10.1016/j.dld.2014.09.020
- Fotbolcu, H., Zorlu, E. (2016). Nonalcoholic fatty liver disease as a multi-systemic disease. World Journal of Gastroenterology, 22 (16), 4079. doi: 10.3748/wjg.v22.i16.4079
- Bazulevuc, A. J. (2015). Non-alcoholic steatohepatitis as a new factor of developing ischaemic heart disease. ScienceRise, 10/3 (15), 171–175. doi: 10.15587/2313-8416.2015.52369
- Dolzhenko, M. M., Bazylevych, A. Ja., Nosenko, N. M. (2011). Vplyv nealkogol'noi' zhyrovoi' hvoroby pechinky na perebig ishemichnoi' hvoroby sercja za danymy dvorichnogo sposterezhennja. Ukrai'ns'kyj kardiologichnyj zhurnal, 2, 67–70.
- Anstee, Q. M., Targher, G., Day, C. P. (2013). Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis. Nature Reviews Gastroenterology & Hepatology, 10 (6), 330–344. doi: 10.1038/nrgastro.2013.41
- Haddad, T. M., Hamdeh, S., Narayanan, M. A. et. al (2015). Nonalcoholic Fatty Liver Disease and the Risk of Clinical Cardiovascular Events: A Meta-Analysis. Circulation, 132, 14339.
- Lonardo, A., Ballestri, S., Targher, G., Loria, P. (2014). Diagnosis and management of cardiovascular risk in nonalcoholic fatty liver disease. Expert Review of Gastroenterology & Hepatology, 9 (5), 629–650. doi: 10.1586/17474124.2015.965143
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2016 Наталія Григорівна Вірстюк, Олена Євгенівна Черкашина, Ірина Ігорівна Вакалюк
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our journal abides by the Creative Commons CC BY copyright rights and permissions for open access journals.
Authors, who are published in this journal, agree to the following conditions:
1. The authors reserve the right to authorship of the work and pass the first publication right of this work to the journal under the terms of a Creative Commons CC BY, which allows others to freely distribute the published research with the obligatory reference to the authors of the original work and the first publication of the work in this journal.
2. The authors have the right to conclude separate supplement agreements that relate to non-exclusive work distribution in the form in which it has been published by the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.
